Assessment of factors affecting mortality in geriatric patients with warfarin overdose

Seda Dagar1, Emine Emektar1, Hüseyin Uzunosmanoglu1

  • 1Department of Emergency Medicine, Kecioren Training and Research Hospital, Ankara, Turkey.

Insights

Elderly patients experiencing warfarin overdose face higher mortality risks due to male gender, advanced age, and impaired liver or kidney function. Close monitoring and patient education are crucial for managing warfarin complications in older adults.

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Internal Medicine

Background:

  • Warfarin is a common anticoagulant medication used in geriatric patients.
  • Warfarin overdose can lead to serious complications, including bleeding and increased mortality.
  • Identifying risk factors for mortality in elderly patients with warfarin overdose is critical for improving patient outcomes.

Purpose of the Study:

  • To conduct a demographic analysis of complications in geriatric patients with warfarin overdose.
  • To determine the factors influencing in-hospital mortality in this patient population.

Main Methods:

  • Retrospective study including patients aged 65+ with an international normalized ratio (INR) > 3.5 IU.
  • Comparison of characteristics between surviving and non-surviving patients.
  • Multivariate logistic regression analysis to identify predictors of in-hospital mortality.

Main Results:

  • A total of 302 geriatric patients were analyzed, with a bleeding rate of 14.2%.
  • Significant differences were observed in age, gender, chronic renal failure, creatinine, AST, and ALT levels between survivors and non-survivors.
  • Predictors of in-hospital mortality included elevated AST and creatinine, advanced age, and male gender.

Conclusions:

  • Male gender, advanced age, and hepatic/renal dysfunction are significant predictors of in-hospital mortality in elderly patients with warfarin overdose.
  • Recommendations include enhanced patient education on warfarin side effects, frequent INR monitoring, and stricter follow-up schedules for older patients, especially those with renal or hepatic impairment.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
109
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
125
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
91
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
156
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
109
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
124